Author:
Spada Marco,Kasper David,Pagliardini Veronica,Biamino Elisa,Giachero Silvana,Porta Francesco
Publisher
Springer Science and Business Media LLC
Reference14 articles.
1. Desnick RJ, Brady RO. Fabry disease in childhood. J Pediatr. 2004;144(5 Suppl):S20–6.
2. Spada M, Enea A, Morrone A, Fea A, Porta F. Cornea verticillata and Fabry disease. J Pediatr. 2013;163:609.
3. Eng CM, Guffon N, Wilcox WR, Germain DP, Lee P, Waldek S, et al. Safety and efficacy of recombinant human alpha-galactosidase a--replacement therapy in Fabry’s disease. N Engl J Med. 2001;345:9–16.
4. Aerts JM, Groener JE, Kuiper S, Donker-Koopman WE, Strijland A, Ottenhoff R, et al. Elevated globotriaosylsphingosine is a hallmark of Fabry disease. Proc Natl Acad Sci U S A. 2008;105:2812–7.
5. Rombach SM, Dekker N, Bouwman MG, Linthorst GE, Zwinderman AH, Wijburg FA, et al. Plasma globotriaosylsphingosine: diagnostic value and relation to clinical manifestations of Fabry disease. Biochim Biophys Acta. 1802;2010:741–8.
Cited by
18 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献